Phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer (072) by Konstantinopoulos, Panagiotis, MD, PhD, Lee, Elizabeth, MD, Xiong, Niya, MS, Krasner, Carolyn, MD, Campos, Susana, MD, Liu, Joyce, MD, MPH, Wright, Alexi, MD, MPH, Sawyer, Hannah, BS, Polak, Madeline, BS, Cheng, Su-Chun, ScD, Matulonis, Ursula, MD, Horowitz, Neil, MD, Bouberhan, Sara, MD, Penson, Richard, MD, Yeku, Oladapo, MD, PhD, FACP, Castro, Cesar, MD, Shea, Meghan, MD

Get full text